Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF

K-Number: K922025 · 1992-09-22

ApplicantPioneering Technologies, Inc.
Decision Date1992-09-22
Product CodeDSY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF is the device name listed in this FDA 510(k) record. The listed applicant is Pioneering Technologies, Inc.. It received FDA 510(k) clearance on 1992-09-22 under 510(k) number K922025. The device is classified under product code DSY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF?

ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF is a medical device that received FDA 510(k) clearance on 1992-09-22. The listed applicant is Pioneering Technologies, Inc.. The 510(k) number is K922025.

When did ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF receive FDA 510(k) clearance?

ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF received FDA 510(k) clearance on 1992-09-22, under 510(k) number K922025.

Who is the listed applicant for ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF?

The FDA 510(k) record lists Pioneering Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF?

The FDA product code for ANASTOMART(TM) CORONARY BYPASS GRAFT MARKERS/MODIF is DSY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Pioneering Technologies, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K905175PTI ANNULOPLASTY RING(STERILE)K905068PTI INTRA-ART (TM) PICK-UP WICKSK910067PTI STERNAL CLOSURE WIRE SUTUREK905067PTI ANASTOMARK FLEXIBLE CORONARY BYPASS GRAFTK901682PTI ANASTOMARK(TM) CORONARY BYPASS GRAFT MARKERSK901815MODIFIED STERILIZATION OF INTRA-ART(TM) CORONARY

View all 19 devices →

Related Devices (Code: DSY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252445Fusion Bioline Vascular GraftMaquet Cardiovascular, LLCK252277Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies LimitedK241550Gelweave™ Vascular ProsthesesVascutek, Ltd.K241070Gelsoft™ Plus Vascular ProsthesesVascutek, Ltd.K231972Advanta VXT Vascular Graft, Flixene Vascular GraftAtrium Medical CorporationK240083GORE® PROPATEN® Vascular GraftW. L. Gore & Associates, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑